ST
IONS icon

Spot Trading’s Ionis Pharmaceuticals IONS Stock Holding History

Spot Trading’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-738
Closed -$38.7K – 3229
2017
Q2 		$38K Sell
738
-11,327
-94% -$527K ﹤0.01% 2884
2017
Q1 		$485K Buy
+12,065
New +$542K 0.02% 1260
2016
Q2 		– Sell
-2,476
Closed -$79.9K – 3552
2016
Q1 		$100K Sell
2,476
-2,819
-53% -$115K ﹤0.01% 2566
2015
Q4 		$328K Sell
5,295
-3,757
-42% -$203K ﹤0.01% 2189
2015
Q3 		$366K Buy
9,052
+8,059
+812% +$417K ﹤0.01% 2266
2015
Q2 		$57K Buy
+993
New +$63.1K ﹤0.01% 3251
2014
Q2 		– Sell
-55
Closed -$1.73K – 4671
2014
Q1 		$2K Sell
55
-19,174
-100% -$929K ﹤0.01% 4079
2013
Q4 		$766K Buy
19,229
+10,378
+117% +$370K ﹤0.01% 2160
2013
Q3 		$332K Sell
8,851
-4,336
-33% -$130K ﹤0.01% 2698
2013
Q2 		$354K Buy
+13,187
New +$280K ﹤0.01% 2663

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Spot Trading's IONS Position: Q3 2017 in Review

Spot Trading sold out of Ionis Pharmaceuticals (IONS) in Q3 2017, closing a stake of 738 shares — an estimated $38.7K sold.

Spot Trading first reported a position in IONS in Q2 2013 and held it in 10 quarters. The position peaked at $766K in Q4 2013. 301 funds tracked by Wall St. Rank hold IONS as of Q3 2017.

  • Spot Trading reported no remaining Ionis Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 738 Ionis Pharmaceuticals shares in Q3 2017, an estimated $38.7K.
  • Spot Trading first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 10 quarters.
  • Spot Trading's Ionis Pharmaceuticals position peaked at $766K in Q4 2013.
  • 301 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.